Zhaolin Zeng

1.4k total citations · 1 hit paper
30 papers, 1.0k citations indexed

About

Zhaolin Zeng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Zhaolin Zeng has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Zhaolin Zeng's work include MicroRNA in disease regulation (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Cancer-related molecular mechanisms research (5 papers). Zhaolin Zeng is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Cancer-related molecular mechanisms research (5 papers). Zhaolin Zeng collaborates with scholars based in China, Canada and United States. Zhaolin Zeng's co-authors include Wang Zuo, Shiyuan Wu, Guohua Li, Hui Xie, Jiaojiao Chen, Xiaolong Lin, Dangheng Wei, Jianghua Liu, Pengfei Qiao and Jun Tao and has published in prestigious journals such as Brain Research, Experimental Cell Research and Advanced Science.

In The Last Decade

Zhaolin Zeng

30 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of pyroptosis in cardiovascular disease

2018 372 citations Zhaolin Zeng, Wang Zuo et al. profile →

Peers

Countries citing papers authored by Zhaolin Zeng

Since Specialization

Citations

This map shows the geographic impact of Zhaolin Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaolin Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaolin Zeng more than expected).

Fields of papers citing papers by Zhaolin Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaolin Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaolin Zeng. The network helps show where Zhaolin Zeng may publish in the future.

Co-authorship network of co-authors of Zhaolin Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaolin Zeng. A scholar is included among the top collaborators of Zhaolin Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaolin Zeng. Zhaolin Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigating the dysregulation of genes associated with glucose and lipid metabolism in gastric cancer and their influence on immunity and prognosis 2024 ·BioFactors ·(unknown), Zhaolin Zeng	1
2	Hepatic Steatosis Aggravates Vascular Calcification via Extracellular Vesicle‐Mediated Osteochondrogenic Switch of Vascular Smooth Muscle Cells 2024 ·Advanced Science ·Zhaolin Zeng, Zhibo Zhao, (unknown), Shiqi Yang, Zhen‐Xing Wang, (unknown), (unknown), (unknown), Qian Chen, (unknown), Xinhua Xiao, Guanghua Luo, (unknown), Juan Li, Xuyu Zu, Hui Xie, Jianghua Liu	2
3	Antibiotic-induced gut microbiota disruption promotes vascular calcification by reducing short-chain fatty acid acetate 2024 ·Molecular Medicine ·(unknown), Yifu Liu, Zhaolin Zeng, Zhibo Zhao, (unknown), Jie Zheng, (unknown), Zhen‐Xing Wang, Hui Xie, Jianghua Liu	4
4	A CEBPB/miR-32–5p/GATA6 axis promotes vascular calcification in type 2 diabetes 2024 ·The International Journal of Biochemistry & Cell Biology ·Zhi Zhao, (unknown), (unknown), Zhaolin Zeng, (unknown), Jingsong Cao, Jianghua Liu, (unknown)	4
5	Potential Effects of Akkermansia Muciniphila in Aging and Aging-Related Diseases: Current Evidence and Perspectives 2023 ·Aging and Disease ·(unknown), Yifu Liu, Jianghua Liu, Zhaolin Zeng, Hui Xie	28
6	Vascular calcification: from the perspective of crosstalk 2023 ·Molecular Biomedicine ·Shiqi Yang, Zhaolin Zeng, (unknown), Qian Chen, (unknown), Hui Xie, Jianghua Liu	10
7	Inhibitory effect of the novel tyrosine kinase inhibitor DCC-2036 on triple-negative breast cancer stem cells through AXL-KLF5 positive feedback loop 2022 ·Cell Death and Disease ·Yingying Shen, (unknown), (unknown), (unknown), (unknown), Jianbo Feng, Jun He, Pei Li, (unknown), Wenjun Ding, Jing Zhong, Zhaolin Zeng, (unknown), Jianghua Liu, Xuyu Zu	14
8	Lnc-PKD2-2-3/miR-328/GPAM ceRNA Network Induces Cholangiocarcinoma Proliferation, Invasion and 5-FU Chemoresistance 2022 ·Frontiers in Oncology ·Lei Zhang, Donglai Ma, Fujun Li, (unknown), Dongsheng Sun, Zhaolin Zeng	5
9	Mitochondrial Stress in Metabolic Inflammation: Modest Benefits and Full Losses 2022 ·Oxidative Medicine and Cellular Longevity ·(unknown), Zhaolin Zeng, Shiqi Yang, Anqi Li, Xuyu Zu, Jianghua Liu	18
10	The expression of m6A enzymes in the hippocampus of diabetic cognitive impairment mice and the possible improvement of YTHDF1 2021 ·Brain Research ·(unknown), Xiaolin Zhong, Zhi Zhao, Zhaolin Zeng, Qing Yuan, Xinhua Xiao, Xuyu Zu, Jianghua Liu	13
11	FGF21 induces autophagy‐mediated cholesterol efflux to inhibit atherogenesis via RACK1 up‐regulation 2020 ·Journal of Cellular and Molecular Medicine ·Xiaolong Lin, (unknown), Mi‐Hua Liu, Wang Zuo, (unknown), (unknown), (unknown), (unknown), (unknown), Jun Lin, Zhaolin Zeng	37
12	FGF21 mitigates atherosclerosis via inhibition of NLRP3 inflammasome-mediated vascular endothelial cells pyroptosis 2020 ·Experimental Cell Research ·Zhaolin Zeng, Qiuping Zheng, Jiaojiao Chen, Xianhua Tan, Qiang Li, (unknown), Ren Zhang, Xiaolong Lin	76
13	Catalpol‑mediated microRNA‑34a suppresses autophagy and malignancy by regulating SIRT1 in colorectal cancer 2020 ·Oncology Reports ·Pengfei Qiao, Lei Yao, Zhaolin Zeng	42
14	TET2 : A Novel Epigenetic Regulator and Potential Intervention Target for Atherosclerosis 2018 ·DNA and Cell Biology ·(unknown), Wen Peng, Kai Qu, Xiaolong Lin, Zhaolin Zeng, Jiaojiao Chen, Dangheng Wei, Wang Zuo	44
15	miR‐23b‐3p and miR‐125b‐5p downregulate apo(a) expression by targeting Ets1 in HepG2 cells 2017 ·Cell Biology International ·(unknown), Zhaolin Zeng, Kai Zhang, Yue Zhao, (unknown), Jiaojiao Chen, (unknown), Dangheng Wei, Zhisheng Jiang, (unknown)	13
16	MicroRNAs: Important Regulators of Induced Pluripotent Stem Cell Generation and Differentiation 2017 ·Stem Cell Reviews and Reports ·Zhaolin Zeng, Xiaolong Lin, (unknown), (unknown), Kai Qu, Zuo Wang	36
17	Application value of end-to-side closed in situ pancreaticojejunostomy in pancreaticoduodenectomy 2015 ·Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi ·Li Yan, Lei Zhang, Zhaolin Zeng	1
18	Sealing Pancreaticojejunostomy in Combination with Duct Parenchyma to Mucosa Seromuscular One-Layer Anastomosis: A Novel Technique to Prevent Pancreatic Fistula after Pancreaticoduodenectomy 2015 ·Journal of the American College of Surgeons ·(unknown), Zhipeng Li, (unknown), Yan Li, Zhaolin Zeng	18
19	Efficient elimination of CD103-expressing cells by anti-CD103 antibody drug conjugates in immunocompetent mice 2014 ·International Immunopharmacology ·(unknown), Zhihui Zhao, Zhaolin Zeng, Xing Wu, Zhengjie Li, Lei Zhang	6
20	Morphological transformation of plant cells in vitro and its effect on plant growth 2005 ·Tsinghua Science & Technology ·(unknown), Zhaolin Zeng, Ruizhi Liu, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact